Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1986 1
1988 2
1994 2
1995 3
1996 4
1997 4
1998 6
1999 3
2000 3
2001 4
2002 3
2003 3
2004 1
2005 1
2006 1
2007 1
2008 2
2009 5
2010 3
2011 5
2012 7
2013 6
2014 3
2015 4
2016 4
2017 3
2018 7
2019 4
2020 5
2021 7
2022 6
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Irritable bowel syndrome and gut microbiota.
Canakis A, Haroon M, Weber HC. Canakis A, et al. Among authors: weber hc. Curr Opin Endocrinol Diabetes Obes. 2020 Feb;27(1):28-35. doi: 10.1097/MED.0000000000000523. Curr Opin Endocrinol Diabetes Obes. 2020. PMID: 31789724 Review.
Gastrointestinal regulatory peptides.
Weber HC. Weber HC. Curr Opin Endocrinol Diabetes Obes. 2022 Apr 1;29(2):167-168. doi: 10.1097/MED.0000000000000719. Curr Opin Endocrinol Diabetes Obes. 2022. PMID: 35197424 No abstract available.
Biomarkers in gastroenteropancreatic neuroendocrine neoplasms.
Jacoba IM, Weber HC. Jacoba IM, et al. Among authors: weber hc. Curr Opin Endocrinol Diabetes Obes. 2023 Jun 1;30(3):175-180. doi: 10.1097/MED.0000000000000805. Epub 2023 Mar 9. Curr Opin Endocrinol Diabetes Obes. 2023. PMID: 36895178 Review.
Gastrointestinal regulatory peptides.
Weber HC. Weber HC. Curr Opin Endocrinol Diabetes Obes. 2011 Feb;18(1):33-4. doi: 10.1097/MED.0b013e32834226fe. Curr Opin Endocrinol Diabetes Obes. 2011. PMID: 21178691 No abstract available.
Irritable bowel syndrome and diet.
Weber HC. Weber HC. Curr Opin Endocrinol Diabetes Obes. 2022 Apr 1;29(2):200-206. doi: 10.1097/MED.0000000000000720. Curr Opin Endocrinol Diabetes Obes. 2022. PMID: 35131984 Review.
Targeted pharmacotherapy of irritable bowel syndrome.
Arokiadoss A, Weber HC. Arokiadoss A, et al. Among authors: weber hc. Curr Opin Endocrinol Diabetes Obes. 2021 Apr 1;28(2):214-221. doi: 10.1097/MED.0000000000000618. Curr Opin Endocrinol Diabetes Obes. 2021. PMID: 33481423 Review.
Diagnostic approaches in COVID-19: clinical updates.
Asrani P, Eapen MS, Chia C, Haug G, Weber HC, Hassan MI, Sohal SS. Asrani P, et al. Among authors: weber hc. Expert Rev Respir Med. 2021 Feb;15(2):197-212. doi: 10.1080/17476348.2021.1823833. Epub 2020 Sep 30. Expert Rev Respir Med. 2021. PMID: 32924671 Review.
Editorial: Gastrointestinal regulatory peptides.
Weber HC. Weber HC. Curr Opin Endocrinol Diabetes Obes. 2021 Apr 1;28(2):196-197. doi: 10.1097/MED.0000000000000613. Curr Opin Endocrinol Diabetes Obes. 2021. PMID: 33428343 No abstract available.
Gastrointestinal regulatory peptides.
Weber HC. Weber HC. Curr Opin Endocrinol Diabetes Obes. 2017 Feb;24(1):1-2. doi: 10.1097/MED.0000000000000303. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 27870640 No abstract available.
117 results